Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder

NCT07220460 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07220460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07220460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Open-label Study to Evaluate the Long-term Safety and Tolerability of ABBV-932 in Subjects With Depressive Episodes Associated With Bipolar I or II Disorder
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 30, 2025
Completion date
April 30, 2027
Enrollment
84 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i or ii disorder